Literature DB >> 16251186

Toward a better understanding of the basis of the molecular mimicry of polysaccharide antigens by peptides: the example of Shigella flexneri 5a.

Marie-Jeanne Clément1, Antoine Fortuné, Armelle Phalipon, Véronique Marcel-Peyre, Catherine Simenel, Anne Imberty, Muriel Delepierre, Laurence A Mulard.   

Abstract

Protein conjugates of oligosaccharides or peptides that mimic complex bacterial polysaccharide antigens represent alternatives to the classical polysaccharide-based conjugate vaccines developed so far. Hence, a better understanding of the molecular basis ensuring appropriate mimicry is required in order to design efficient carbohydrate mimic-based vaccines. This study focuses on the following two unrelated sets of mimics of the Shigella flexneri 5a O-specific polysaccharide (O-SP): (i) a synthetic branched pentasaccharide known to mimic the average solution conformation of S. flexneri 5a O-SP, and (ii) three nonapeptides selected upon screening of phage-displayed peptide libraries with two protective murine monoclonal antibodies (mAbs) of the A isotype specific for S. flexneri 5a O-SP. By inducing anti-O-SP antibodies upon immunization in mice when appropriately presented to the immune system, the pentasaccharide and peptides p100c and p115, but not peptide p22, were qualified as mimotopes of the native antigen. NMR studies based on transferred NOE (trNOE) experiments revealed that both kinds of mimotopes had an average conformation when bound to the mAbs that was close to that of their free form. Most interestingly, saturation transfer difference (STD) experiments showed that the characteristic turn conformations adopted by the major conformers of p100c and p115, as well as of p22, are clearly involved in mAb binding. These latter experiments also showed that the branched glucose residue of the pentasaccharide was a key part of the determinant recognized by the protective mAbs. Finally, by using NMR-derived pentasaccharide and peptide conformations coupled to STD information, models of antigen-antibody interaction were obtained. Most interestingly, only one model was found compatible with experimental data when large O-SP fragments were docked into one of the mIgA-binding sites. This newly made available system provides a new contribution to the understanding of the molecular mimicry of complex polysaccharides by peptides and short oligosaccharides.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251186     DOI: 10.1074/jbc.M510172200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Identification and characterization of peptide mimics of blood group A antigen.

Authors:  Zhaoming Tang; Lin Wang; Lihua Hu; Yirong Li; Tianpen Cui; Juan Xiong; Lifang Dou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-05-15

2.  Close-up of the immunogenic α1,3-galactose epitope as defined by a monoclonal chimeric immunoglobulin E and human serum using saturation transfer difference (STD) NMR.

Authors:  Melanie Plum; Yvonne Michel; Katharina Wallach; Tim Raiber; Simon Blank; Frank I Bantleon; Andrea Diethers; Kerstin Greunke; Ingke Braren; Thomas Hackl; Bernd Meyer; Edzard Spillner
Journal:  J Biol Chem       Date:  2011-10-11       Impact factor: 5.157

3.  Immunological evidence for functional rather than structural mimicry by a Shigella flexneri Y polysaccharide-mimetic peptide.

Authors:  Silvia Borrelli; Rehana B Hossany; B Mario Pinto
Journal:  Clin Vaccine Immunol       Date:  2008-05-07

4.  A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120.

Authors:  Alfredo Menendez; Daniel A Calarese; Robyn L Stanfield; Keith C Chow; Chris N Scanlan; Renate Kunert; Herman Katinger; Dennis R Burton; Ian A Wilson; Jamie K Scott
Journal:  FASEB J       Date:  2008-01-15       Impact factor: 5.191

5.  Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction.

Authors:  Frederic Jabs; Melanie Plum; Nick S Laursen; Rasmus K Jensen; Brian Mølgaard; Michaela Miehe; Marco Mandolesi; Michèle M Rauber; Wolfgang Pfützner; Thilo Jakob; Christian Möbs; Gregers R Andersen; Edzard Spillner
Journal:  Nat Commun       Date:  2018-01-02       Impact factor: 14.919

6.  Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell Proliferation.

Authors:  Aurélie Philippe; Gunnar Kleinau; Jason Jannis Gruner; Sumin Wu; Daniel Postpieszala; David Speck; Harald Heidecke; Simon J Dowell; Gabriela Riemekasten; Peter W Hildebrand; Julian Kamhieh-Milz; Rusan Catar; Michal Szczepek; Duska Dragun; Patrick Scheerer
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923

Review 7.  Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting.

Authors:  David Speck; Gunnar Kleinau; Michal Szczepek; Dennis Kwiatkowski; Rusan Catar; Aurélie Philippe; Patrick Scheerer
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-19       Impact factor: 6.055

Review 8.  Carbohydrate-mimetic peptides for pan anti-tumor responses.

Authors:  Thomas Kieber-Emmons; Somdutta Saha; Anastas Pashov; Behjatolah Monzavi-Karbassi; Ramachandran Murali
Journal:  Front Immunol       Date:  2014-06-30       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.